ACRO Biomedical Co

ACRO Biomedical Co EBIT per Share

The EBIT per Share of ACRO Biomedical Co (6748.TWO) as of Sep 27, 2026 is -1.52 TWD. In the previous year, EBIT per Share was -1.09 TWD — a change of 39.67% (lower).

EBIT per Share

-1.52TWD

YoY

39.67%

Last updated:

EBIT per Share of ACRO Biomedical Co is 2026 -1.52 TWD. EBIT per Share of ACRO Biomedical Co was 2025 -1.09 TWD. It decreases by 39.67% lower compared to the previous year.

The ACRO Biomedical Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-1.19 TWD
Jan 1, 2020
-0.91 TWD
Jan 1, 2021
-0.87 TWD
Jan 1, 2022
-1.22 TWD
Jan 1, 2023
-0.84 TWD
Jan 1, 2024
-1.09 TWD
Jan 1, 2025
-1.52 TWD
The ACRO Biomedical Co EBIT per Share history
YEAREBIT per ShareYoY
-1.52TWD+39.67%
-1.09TWD+29.52%
-0.84TWD-31.22%
-1.22TWD+39.39%
-0.87TWD-4.31%
-0.91TWD-23.03%
-1.19TWD—
Access this data via the Eulerpool API
Get Free API Key

ACRO Biomedical Co Stock analysis

What does ACRO Biomedical Co do? ACRO Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ACRO Biomedical Co stock

EBIT per Share of ACRO Biomedical Co is -1.52 TWD in 2026.

EBIT per Share of ACRO Biomedical Co changed from -1.09 TWD to -1.52 TWD, representing a 39.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share ACRO Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — ACRO Biomedical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — ACRO Biomedical Co